이뮨온시아 이뮨온시아 이뮨온시아 이뮨온시아
  • Home
  • Immunotherapy
  • Pipeline
  • News and Publications
  • About us
  • Contact us

News and Publications

Previous Next

전자증권 전환 대상 주권 권리자[주주] 보호 및 조치사항 안내


By admin| 2022-09-20T11:09:34+00:00 2022/09/20|News and Publications|0 Comments

    H.Q: 25, Tapsil-ro 35beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 17084, Republic of Korea

    R&D Center: Suite 6F, Genexine ProGen Bio Innovation Park, 172, Magokjungang-ro, Gangseo-gu, Seoul, 07789, Replublic of Korea

    Copyright © ImmuneOncia. All Rights Reserved.

FacebookTwitterInstagramPinterest